semaglutide tirzepatide combination vs. Semaglutide: Which Weight Loss Medication is Right for You? Semaglutide vs. Tirzepatide: Which GLP-1

For the scientific community, the future involves: Continued Retatrutide Trials: Monitoring the outcomes of Retatrutide's Phase 3 clinical trials to understand its full efficacy and safety profile as a monotherapy

doi: 10.1038/s41577-024-01014-8 123

Choose the method that works best for you

The most common side effects reported in the tirzepatide groups were diarrhea and nausea.In patients with type 2 diabetes who had inadequate control of blood sugar levels despite treatment with insulin glargine, adding subcutaneous tirzepatide to titrated insulin glargine led to significant improvements in glycemic control after 40 weeks, along with reductions in body weight